Author:
Yang Hongyu,Liu Huipan,Zhang Yu,Zhang Yu,Chen Yue
Abstract
Abstract
A 56-year-old man with metastatic lung adenocarcinoma received combined 177Lu-FAP-2286 radiation therapy and targeted therapy. After 1 treatment cycle, improvement of symptoms and radiological remission was observed. Moreover, the patient did not report any adverse effects.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献